C12N 2501/71
Oxidoreductases
Official title: Oxidoreductases (EC 1.)
C12N2501/71 (Oxidoreductases) appears on 52 US grants and 133 published applications in this corpus.
Search patents in C12N- Granted patents
- 52
- Published applications
- 133
- Assignees
- 82
- Inventors
- 220
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 4 |
| 2014 | 1 | 3 |
| 2015 | 4 | 3 |
| 2016 | 6 | 4 |
| 2017 | 1 | 13 |
| 2018 | 5 | 18 |
| 2019 | 7 | 17 |
| 2020 | 9 | 8 |
| 2021 | 5 | 13 |
| 2022 | 1 | 5 |
| 2023 | 2 | 8 |
| 2024 | 4 | 12 |
| 2025 | 5 | 13 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Media for culturing naive human pluripotent stem cells14 Jul 2026US 12,680,083 B2Yeda Research and Development Co. Ltd.
- Method for maturation of retinal tissue containing continuous epithelium27 Jan 2026US 12,534,706 B2Racthera Co., Ltd.
- Composition for culturing peripheral blood monocyte-derived regulatory t cell and regulatory T cell culturing method using same18 Nov 2025US 12,473,534 B2Immunisbio Co., Ltd.
- Selective oxidation of 5-methylcytosine by tet-family proteins11 Nov 2025US 12,467,082 B2Children's Medical Center Corporation
- Selective oxidation of 5-methylcytosine by TET-family proteins24 Jun 2025US 12,338,489 B2Children's Medical Center Corporation
- Small Molecule Based Method Of Modifying T Cells8 Oct 2026US 2026/0308520 A1Agency for Science, Technology and Research
- T cell progenitor production method1 Oct 2026US 2026/0297522 A1Kyoto University
- Culture Medium, Production Method, and Cell Preparation1915570424 Sep 2026US 2026/0286306 A1National University Corporation Kumamoto University
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Method for promoting generation of mitochondria-containing microvesicle, method for generating extracellular vesicle composition, extracellular vesicle composition, and pharmaceutical composition and application thereof26 Feb 2026US 2026/0055372 A1Kingbios Co., Ltd.
Most cited
By later US patents
- Selective oxidation of 5-methylcytosine by TET-family proteins46US 9,447,452 B2Children's Medical Center Corporation · 2016
- Selective oxidation of 5-methylcytosine by TET-family proteins41US 9,115,386 B2Children's Medical Center Corporation · 2015
- Detection of 5-hydroxymethylcytosine by glycosylation33US 9,816,986 B2Children's Medical Center Corporation · 2017
- Selective oxidation of 5-methylcytosine by TET-family proteins26US 10,031,131 B2Children's Medical Center Corporation · 2018
- Labeling hydroxymethylated residues26US 10,337,053 B2Children's Medical Center Corporation · 2019